Reports
Reports
Sale
The global nucleic acid labeling market size was valued at USD 2.4 billion in 2023, driven by the increasing investments by key players in research and development activities across the globe. The market size is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 to achieve a value of USD 5.1 billion by 2032.
The process of nucleic acid labeling is crucial in identifying particular DNA or RNA sequences present in unknown samples. Specific sequences of nitrogenous bases are integrated into the nucleic acid molecules before being labeled. These labels can be used to detect and purify nucleic acids with ease. Labeling of nucleic acids can be done by several methods. Some common labels used to generate nucleic acid probes include radioactive phosphates, biotin, fluorophores, and enzymes.
The market has been witnessing significant growth in demand owing to the rising investments by major key players in the market. For example, Agilent Technologies Inc. invested about 725 million earlier this year to double the manufacturing capacity of therapeutic nucleic acids in response to the rapid growth of the market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).
Additionally, the market growth is driven by the ongoing acquisitions between key players to expand the market. Novartis is a leading pharmaceutical company that may share resources and expertise to catalyze DTx Pharma's research and development efforts in the field. Such developments are expected to further propel the nucleic acid labeling market growth. This could lead to advancements in siRNA therapies for neuroscience indications, potentially expanding the applications of nucleic acid labeling technologies. This acquisition is expected to result in an expanded adoption of nucleic acid labeling methods. The adoption would be prominent especially if these technologies become integral to the development and production of siRNA therapies, bolstering the market growth.
Market Breakup by Product
Market Breakup by Technique
Market Breakup by Application
Market Breakup by Region
The growing need for personalized medicine has opened numerous opportunities in the field of genetic medicine. This has led to the development of novel technologies, which has resulted in the rapid expansion of the market. Consequently, the global nucleic acid labeling market is experiencing significant growth, driven by the increasing focus on personalized medicine and a patient-centred approach.
The global market, based on demand, has been dominated by North America and is expected to be dominated in the forecast period as well. The market growth is significantly driven by the increasing prevalence of chronic diseases such as cancer. The market demand is also driven by the growing geriatric population, coupled with the growing demand for targeted and personalized medicine, and favourable government initiatives.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Technique |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nucleic Acid Labeling Market Overview
3.1 Global Nucleic Acid Labeling Market Historical Value (2017-2023)
3.2 Global Nucleic Acid Labeling Market Forecast Value (2024-2032)
4 Global Nucleic Acid Labeling Market Landscape
4.1 Global Nucleic Acid Labeling Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nucleic Acid Labeling Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Nucleic Acid Labeling Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nucleic Acid Labeling Market Segmentation
6.1 Global Nucleic Acid Labeling Market by Product
6.1.1 Market Overview
6.1.2 Reagent and Kits
6.1.3 Services
6.2 Global Nucleic Acid Labeling Market by Technique
6.2.1 Market Overview
6.2.2 PCR
6.2.3 Nick Translation
6.2.4 Random Primer
6.2.5 In Vitro Transcription
6.2.6 Reverse Transcription
6.2.7 End Labelling
6.3 Global Nucleic Acid Labeling Market by Application
6.3.1 Market Overview
6.3.2 DNA Sequencing
6.3.3 Polymerase Chain Reaction
6.3.4 Microarray
6.3.5 In Situ Hybridization
6.3.6 Others
6.4 Global Nucleic Acid Labeling Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Nucleic Acid Labeling Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nucleic Acid Labeling Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nucleic Acid Labeling Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nucleic Acid Labeling Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nucleic Acid Labeling Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Thermo Fisher Scientific Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 New England Biolabs.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 PerkinElmer Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 F. Hoffmann La-Roche AG
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 GENERAL ELECTRIC COMPANY
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Merck KGaA
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Enzo Biochem Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Promega Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Vector Laboratories
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Agilent Technologies, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 LubioScience GmbH
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 VWR International, LLC
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Marker Gene Technologies, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Interchim
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Helix OpCo LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Cytiva
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Nucleic Acid Labeling Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 2.4 billion in 2023, driven by the increasing prevalence of chronic diseases.
The market is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032, likely to reach a market value of USD 5.1 billion by 2032.
The increasing demand for personalized medicines is a major factor that is driving the market growth.
Increasing investments by the key players to expand the capacity to manufacture active pharmaceutical ingredients is among the major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different techniques of nucleic acid labeling include PCR, nick translation, random primer, in vitro transcription, reverse transcription, and end labeling.
Different products include reagents, kits, and services.
They find wide applications in DNA sequencing, polymerase chain reaction, microarray, and in situ hybridization, among others.
Key players involved in the market are Thermo Fisher Scientific Inc., New England Biolabs., PerkinElmer Inc., F. Hoffmann La-Roche AG, GENERAL ELECTRIC COMPANY, Merck KGaA, Enzo Biochem Inc., Promega Corporation, Vector Laboratories, Agilent Technologies, Inc., LubioScience GmbH, VWR International, LLC, Marker Gene Technologies, Inc., Interchim, Helix OpCo LLC, and Cytiva.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.